Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 1, January, p. 133–135

doi: 10.17219/acem/76751

Publication type: review

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Mortality predictor pattern in hemodialysis and peritoneal dialysis in diabetic patients

Marian Klinger1,A,B,C,D,E,F, Katarzyna Madziarska1,A,B,C,D,E,F

1 Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Poland

Abstract

An excessive mortality in dialysis programs is the result of cardiovascular injuries and immune deficiency caused by uremic toxins. The vulnerability of dialysis patients is still increasing due to the growing number of diabetics, elderly and patients with a history of cardiovascular disease. Peritoneal dialysis (PD) and hemodialysis (HD) offer similar effectiveness during the first 2 years of the treatment. However, the survival advantage of HD subsequently appears. The problem of the factors responsible for the mortality during long-term PD and HD treatment was analyzed in our recently published investigation. A lower death risk for PD patients during the first several months was lessened over time, and, therefore, no survival advantage of PD was noticeable by the completion of the 2-year period. A sign of the diminishing benefit of PD was a high rate of modality switch – 57%, contrasting with 6% switched in the HD group. Longer observations confirmed that the extension of the treatment period above 2 years with HD was associated with improved survival among subgroups with cardiovascular disease and diabetes. A very relevant problem is the timely transfer of PD patients to the HD program, when an adequate nutritional intake cannot be ascertained and a decline of serum albumin level is observed. The aim of this overview was to compare the factors affecting the survival of diabetic patients in HD and PD patients.

Key words

hemodialysis, elderly, mortality, peritoneal dialysis, diabetics

References (10)

  1. Stel VS, van de Luijtgaarden MW, Wanner C, Jager KJ; on behalf of the European Renal Registry Investigators. The 2008 ERA-EDTA Registry Annual Report-a précis. NDT Plus 2011;4(1):1–13.
  2. Keshaviah P, Collins AJ, Ma JZ, Churchill DN, Thorpe KE. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J Am Soc Nephrol. 2002;13(Suppl 1):S48–S52.
  3. Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: A marginal structural model analysis. Clin J Am Soc Nephrol. 2013;8(4):619–628.
  4. Lee J-H, Park S-H, Lim J-H, et al. Impact of dialysis modality on technique survival in end-stage renal disease patients. Korean J Intern Med. 2016;31(1):106–115.
  5. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010;21(3):499–506.
  6. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT; Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol. 2003;14(11):2851–2860.
  7. Madziarska K, Weyde W, Penar J, et al. Different mortality predictor pattern in hemodialysis and peritoneal dialysis diabetic patients in 4-year prospective observation. Postepy Hig Med Dosw (Online). 2013;67:1076–1082.
  8. Browne OT, Allgar V, Bhandari S. Analysis of factors predicting mortality of new patients commencing renal replacement therapy: 10 years of follow-up. BMC Nephrology.2014;20:15–20.
  9. Han SH, Han DS. Nutrition in patients on peritoneal dialysis. Nat Rev Nephrol.2012;8(3):163–175.
  10. Ikizler TA, Cano NJ, Franch H, et al.; International Society of Renal Nutrition and Metabolism. Prevention and treatment of protein energy wasting in chronic kidney disease patients: A consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096–1107.
© Wroclaw Medical University